Bo Ying

2.1k total citations
26 papers, 388 citations indexed

About

Bo Ying is a scholar working on Molecular Biology, Infectious Diseases and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Bo Ying has authored 26 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Infectious Diseases and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Bo Ying's work include RNA Interference and Gene Delivery (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and RNA modifications and cancer (3 papers). Bo Ying is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and RNA modifications and cancer (3 papers). Bo Ying collaborates with scholars based in China, United States and Belarus. Bo Ying's co-authors include R. B. Campbell, Geoffrey Kuesters, Zhi‐Qi Zhao, Ning Lü, Yu‐Qiu Zhang, Frederick W. Unverzagt, Chaoke Liang, Yinlong Jin, Jianzhao Shen and Feng Ma and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Bo Ying

25 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ying China 9 159 62 54 47 42 26 388
Zeeshan Ali China 12 243 1.5× 33 0.5× 27 0.5× 104 2.2× 30 0.7× 24 435
Zhiwei Liu China 11 126 0.8× 26 0.4× 89 1.6× 32 0.7× 17 0.4× 31 381
Rachida Legssyer Belgium 8 151 0.9× 13 0.2× 73 1.4× 21 0.4× 69 1.6× 9 639
Edyta Bajak Sweden 12 258 1.6× 20 0.3× 112 2.1× 32 0.7× 27 0.6× 13 508
Drishtant Singh India 11 137 0.9× 62 1.0× 23 0.4× 38 0.8× 24 0.6× 26 460
M. Leroux France 14 186 1.2× 15 0.2× 138 2.6× 40 0.9× 26 0.6× 37 612
L. V. Puchkova Russia 16 163 1.0× 14 0.2× 225 4.2× 35 0.7× 32 0.8× 74 676
Jianhua Yang China 16 213 1.3× 14 0.2× 38 0.7× 31 0.7× 25 0.6× 29 524
Manali Datta India 13 134 0.8× 9 0.1× 68 1.3× 51 1.1× 16 0.4× 33 401
Victoria Hodgkinson Canada 12 311 2.0× 11 0.2× 130 2.4× 37 0.8× 122 2.9× 22 739

Countries citing papers authored by Bo Ying

Since Specialization
Citations

This map shows the geographic impact of Bo Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ying more than expected).

Fields of papers citing papers by Bo Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ying. The network helps show where Bo Ying may publish in the future.

Co-authorship network of co-authors of Bo Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ying. A scholar is included among the top collaborators of Bo Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ying. Bo Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Yu, et al.. (2025). Development and characterization of a miRNA-responsive circular RNA expression system with cell type specificity. Molecular Therapy — Nucleic Acids. 36(1). 102450–102450. 3 indexed citations
2.
Zhang, Guangxu, Qian Wang, Kai Ji, et al.. (2025). Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad‐Neutralizing Antibody Response against SARS‐CoV‐2 Omicron Subvariants. MedComm. 6(7). e70273–e70273. 1 indexed citations
3.
Ying, Bo, et al.. (2024). Efficient circularization of protein-encoding RNAs via a novel cis-splicing system. Nucleic Acids Research. 52(17). 10400–10415. 7 indexed citations
4.
Chi, Hang, Rongrong Zhang, Wenhui Yang, et al.. (2024). Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses. Signal Transduction and Targeted Therapy. 9(1). 69–69. 8 indexed citations
5.
Zhang, Yuxin, Zhen Wei, Daiyun Huang, et al.. (2024). NanoMUD: Profiling of pseudouridine and N1-methylpseudouridine using Oxford Nanopore direct RNA sequencing. International Journal of Biological Macromolecules. 270(Pt 2). 132433–132433. 7 indexed citations
6.
Hannawi, Suad, Xiaohong Wu, Ralph Elvi Villalobos, et al.. (2024). Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial. Med. 5(10). 1282–1292.e3. 4 indexed citations
7.
Liu, Jingjing, Xishan Lu, Xingxing Li, et al.. (2023). Construction and immunogenicity of an mRNA vaccine against chikungunya virus. Frontiers in Immunology. 14. 1129118–1129118. 7 indexed citations
8.
Ye, Qing, Mei Wu, Chao Zhou, et al.. (2022). Rational development of a combined mRNA vaccine against COVID-19 and influenza. npj Vaccines. 7(1). 84–84. 33 indexed citations
9.
Wang, Xianliang, Jiao Wang, Jin Shen, et al.. (2021). Facilities for Centralized Isolation and Quarantine for the Observation and Treatment of Patients with COVID-19. Engineering. 7(7). 908–913. 18 indexed citations
10.
Bai, Ailin, Susannah L. Hewitt, John Zielinski, et al.. (2017). Abstract 1607: Durable efficacy and anti-cancer immunity following intratumoral administration of messenger RNAs encoding IL-36γ, IL-23 and OX40L. Cancer Research. 77(13_Supplement). 1607–1607. 1 indexed citations
11.
Ganesh, Shanthi, Martin L. Koser, Junyan Tao, et al.. (2016). Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin. Molecular Cancer Therapeutics. 15(9). 2143–2154. 50 indexed citations
12.
Ganesh, Shanthi, Bo Ying, Martin L. Koser, et al.. (2015). Abstract 3533: Systemic delivery of CTNNB1 Dicer-substrate siRNAs (DsiRNAs) leads to efficient oncogene silencing in diverse tumor types of extra hepatic origin. Cancer Research. 75(15_Supplement). 3533–3533. 1 indexed citations
13.
Ying, Bo & R. B. Campbell. (2014). Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature. Biochemical and Biophysical Research Communications. 446(2). 441–447. 17 indexed citations
14.
Wortham, Kathleen, Bo Ying, Hailin Yang, et al.. (2013). Abstract B222: Dicer substrate siRNAs to MYC, B-catenin, and other target genes effectively induce in vivo target gene knockdown and tumor inhibition.. Molecular Cancer Therapeutics. 12(11_Supplement). B222–B222. 1 indexed citations
15.
Ying, Bo & Luo Li. (2010). Distribution characteristics of arsenic in environment of Bayannaoer, Inner Mongolia.. Journal of environmental health. 27(8). 696–699. 5 indexed citations
16.
Ying, Bo & Luo Li. (2010). Geochemical Characteristics of Arsenic in Waterbodies in Hetao Plain,Inner Mongolia. Shengtai yu nongcun huanjing xuebao. 26(1). 31–34. 1 indexed citations
17.
Gao, Sujuan, Yinlong Jin, Frederick W. Unverzagt, et al.. (2008). Trace Element Levels and Cognitive Function in Rural Elderly Chinese. The Journals of Gerontology Series A. 63(6). 635–641. 53 indexed citations
18.
Campbell, R. B., et al.. (2008). Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics. Journal of Pharmaceutical Sciences. 98(2). 411–429. 82 indexed citations
19.
Ying, Bo. (2006). Determination of Aroma in Laoshan Green Tea by GC/MS(I). 1 indexed citations
20.
Ying, Bo, Ning Lü, Yu‐Qiu Zhang, & Zhi‐Qi Zhao. (2006). Involvement of spinal glia in tetanically sciatic stimulation-induced bilateral mechanical allodynia in rats. Biochemical and Biophysical Research Communications. 340(4). 1264–1272. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeeshan Ali Breakdown of academic impact, for papers by Zhiwei Liu Breakdown of academic impact, for papers by Rachida Legssyer Breakdown of academic impact, for papers by Edyta Bajak Breakdown of academic impact, for papers by Drishtant Singh Breakdown of academic impact, for papers by M. Leroux Breakdown of academic impact, for papers by L. V. Puchkova Breakdown of academic impact, for papers by Jianhua Yang Breakdown of academic impact, for papers by Manali Datta Breakdown of academic impact, for papers by Victoria Hodgkinson
Rankless by CCL
2026